Skip to main content
Philogen logo

Philogen — Investor Relations & Filings

Ticker · PHIL ISIN · IT0005373789 LEI · 81560009EA1577917768 XMIL Manufacturing
Open in API
Filings indexed 377 across all filing types
Latest filing 2025-05-07 Director's Dealing
Country IT Italy
Listing XMIL PHIL

About Philogen

https://www.philogen.com

Philogen is a clinical-stage biotechnology company focused on the discovery and development of novel biopharmaceutical products for the treatment of cancer and other serious conditions associated with angiogenesis. Founded in 1996, the company's core strategy is based on innovating targeted therapies, such as antibody-cytokine fusions, which are designed to selectively deliver therapeutic agents to the site of disease. This approach aims to increase efficacy while reducing toxicity. Philogen operates as an integrated company with capabilities in research, GMP manufacturing, and clinical development of its proprietary product pipeline.

Recent filings

Filing Released Lang Actions
Allegato 3F
Director's Dealing Classification · 99% confidence The document is titled "SCHEMA DI COMUNICAZIONE DELLE OPERAZIONI SUI TITOLI DELL'EMITTENTE" (Model Disclosure for Transactions in the Issuer's Securities) and details transactions conducted by a party (MEDIOBANCA) concerning the shares of PHILOGEN S.p.A. The structure, use of tables detailing 'SOGGETTO' (Party), 'STRUMENTO FINANZIARIO' (Financial Instrument), and 'OPERAZIONI' (Transactions) with dates, quantities, and prices, strongly indicates a mandatory regulatory filing concerning insider or related-party trading activity. This aligns perfectly with the definition of Director's Dealing (DIRS), which covers personal share transactions by directors and executives, or in this broader context, transactions by related parties that must be disclosed. Since the transaction is reported by MEDIOBANCA (likely a major shareholder or related entity) regarding PHILOGEN shares, it falls under the category for reporting personal/insider share transactions.
2025-05-07 Italian
Il Consiglio di Amministrazione approva la posizione finanziaria netta relativa al Primo Trimestre 2025
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive report from Philogen S.p.A. detailing the financial position (Net Financial Position) for the first quarter of 2025, along with detailed updates on clinical trials, industrial activities, and corporate governance decisions (such as the share buyback program). It contains substantive financial data, including a balance sheet table for the period ending March 31, 2025. Since it provides actual financial statements and analysis for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report. Q1 2025
2025-05-06 Italian
Comunicato stampa Assemblea 29 aprile 2025
AGM Information Classification · 98% confidence The document details the resolutions passed during the 'Assemblea degli Azionisti 2025' (Annual Shareholders' Meeting) of Philogen S.p.A. Key actions include the approval of the 2024 financial statements, deliberation on profit distribution, approval of the Remuneration Policy (referencing art. 123-ter of TUF), appointment of the new Board of Directors, approval of incentive plans (Stock Grant and Directors' Shareholding Plans), authorization for share buybacks, and a free capital increase. The text also includes the subsequent resolutions taken by the newly appointed Board of Directors (appointment of CEO, confirmation of independent directors, etc.). Since the document summarizes the outcomes and decisions made during the Annual General Meeting, it directly corresponds to the 'AGM Information' category.
2025-04-29 Italian
Allegato 3F
Director's Dealing Classification · 98% confidence The document is titled "SCHEMA DI COMUNICAZIONE DELLE OPERAZIONI SUI TITOLI" / "MODEL DISCLOSURE FOR TRANSACTIONS IN THE ISSUER'S SECURITIES". It details transactions (purchases/sales, indicated by 'A' for Acquisto/Buy) conducted by a party (MEDIOBANCA) concerning the shares of the issuer (PHILOGEN S.p.A.) over specific dates in March 2025. This structure precisely matches the reporting requirements for insider transactions or significant share dealings by related parties. Among the provided definitions, 'Director's Dealing' (Code: DIRS) is the closest fit, as it covers reports of personal share transactions by directors and executives, which often extends to major related parties or significant transactions disclosed in this format, especially when dealing with transactions in the issuer's own securities.
2025-04-14 Italian
2025 04 14 - CS settimanale acquisto azioni proprie
Transaction in Own Shares Classification · 100% confidence The document is titled 'AGGIORNAMENTO SUL PROGRAMMA DI ACQUISTO DI AZIONI PROPRIE' (Update on the Share Buyback Program) and details the number of own shares purchased by Philogen S.p.A. during a specific period (April 7 to April 11, 2025), including daily transaction breakdowns. This activity directly relates to the company managing its own stock capital by repurchasing shares. This aligns perfectly with the definition for 'Transaction in Own Shares' (Code: POS). The document is a formal announcement detailing the execution of a share repurchase program, not a general regulatory filing (RNS) or a report publication announcement (RPA), as it contains the substantive data itself.
2025-04-14 English
Informazioni sull'ammontare complessivo dei diritti di voto
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document title is "COMUNICAZIONE DELL'AMMONTARE COMPLESSIVO DEI DIRITTI DI VOTO" (Communication of the Total Amount of Voting Rights). It explicitly states that it is communicating the total number of voting rights in view of an upcoming Shareholders' Meeting ('Assemblea degli Azionisti') on April 29, 2025, citing Italian regulatory requirements (Consob). This content directly relates to the official results or necessary pre-meeting disclosures concerning shareholder voting power. Among the provided codes, 'Declaration of Voting Results & Voting Rights Announcements' (DVA) is the most appropriate fit for a formal communication detailing the total voting rights ahead of a general meeting, as it pertains to the mechanics of shareholder voting.
2025-04-11 Italian

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.